What are CBD-infused drinks and what is their legal status in the European Union?
The scientific foundation for CBD in beverages involves two separate questions: does CBD have documented physiological effects, and can those effects be delivered in a beverage format at realistic doses? The first question has a clear answer: yes. CBD has been shown in clinical trials to have anxiolytic (anti-anxiety), anticonvulsant and anti-inflammatory effects. The pharmaceutical CBD product Epidiolex is FDA-approved and EMA-approved for seizure disorders. The anti-anxiety effects of CBD in doses of 300-600mg are well-documented in human trials.
The second question is more complex. CBD is lipophilic — it dissolves in oil, not water. Put CBD in water and it immediately comes out of solution and settles. This fundamental chemistry problem means that most CBD waters and drinks on the market deliver very low bioavailability — the CBD is present but your body cannot absorb much of it through the gastrointestinal tract in that form. The solutions are: nanoemulsion technology (breaking CBD into nano-scale droplets that remain suspended in water), liposomal encapsulation (wrapping CBD in lipid spheres that survive the gut), or emulsification with food-grade surfactants. The best CBD beverages use these technologies; many cheaper ones do not.
The typical dose in a CBD beverage (15-50mg per can) is also significant. The clinical evidence for anxiety effects is built on doses of 150-600mg/day. A single 250ml CBD drink with 25mg of CBD, even if fully bioavailable, is at the very bottom of the range where measurable effects would be expected. This doesn't mean the drink does nothing — ritual, expectation and the synergistic effects of other botanicals (often included alongside the CBD) may contribute — but the specific "CBD does X" claim for the amount in a beverage is difficult to defend scientifically.
The regulatory picture is evolving. The EFSA Novel Foods assessment of CBD is ongoing and expected to report in 2025. If CBD receives a positive opinion with established acceptable daily intakes, it could transform the EU market overnight — legitimising CBD beverages in all member states and enabling brands to make evidence-based claims. Belgium has a particularly nuanced position: CBD-based food products with < 0.2% THC are generally tolerated by the FASFC (Federal Agency for the Safety of the Food Chain) though not formally approved.
| EU Country | CBD food/beverage status (2024) |
|---|---|
| Switzerland | Legal for food use (not EU but aligned) |
| Netherlands | Tolerated, actively sold |
| Belgium | Tolerated with FASFC nuance (< 0.2% THC) |
| Germany | Novel Foods queue — grey zone, often sold |
| France | CBD food prohibited (fleurs only for flower sector) |
| UK (post-Brexit) | Novel Foods — permitted with FSA guidance |
zeroproof.one covers the CBD beverage category with regulatory context and quality recommendations — find guidance in the Functional Beverages section.